News
Greehey CCRI Faculty Awarded $1.2M CPRIT Grant to Support Osteosarcoma Research
Written by: Will Sansom An award of $1.2 million from the Cancer Prevention and Research Institute of Texas (CPRIT) went to Greehey CCRI Deputy Director and principal investigator Manjeet Rao, Ph.D., professor of cell systems and anatomy, for studies o …
Luiz O.F. Penalva, Ph.D., Co-corresponding Senior Author on NPJ Genomic Medicine publication.
“Proneural and mesenchymal glioma stem cells display major differences in splicing and lncRNA profiles” Abstract Therapy resistance and recurrence in high-grade gliomas are driven by their populations of glioma stem cells (GSCs). Thus, detailed molecul …
BISHOP LAB: Pipette Gazette, Kevin Kanda, From Nursing Student To Graduate Student
Kevin Kanda made a promise to his family to try to fight cancer.
Adam Kosti from Penalva Lab Publishes First, First-Author Paper
ELF4 is a Target of miR-124 and Promotes Neuroblastoma Proliferation and Undifferentiated State Abstract 13-Cis-retinoic acid (RA) is typically used in postremission maintenance therapy in patients with neuroblastoma. However, side effects and recurren …
NATURE: Bishop lab helps discovery of R-loops in the pediatric cancer Embryonal tumors with multilayered rosettes (ETMRs)
SCITECH EUROPA: Preclinical Drug Development for Childhood Cancers
Nicole Hensch of the Ignatius Lab Receives The Greehey Graduate Fellowship in Children’s Health
MISSION MAGAZINE: Tiny molecule has big effect in childhood brain cancer
Sometimes small things make the biggest difference. A new study has found that a molecule thousands of times smaller than a gene is able to kill medulloblastoma, the most common childhood brain cancer. This tiny molecule, named MiR-584-5p, is quite eff …